EGFR and neoplasm: Several malignancies have been noted to show high or abnormal EGFR expression, thereby precipitating sustained activation and amplification of downstream signaling pathways, stimulating physiological and pathological angiogenesis to enhance blood supply to the tumor [28, 29].